Insights On Outsourced Drug Development

  1. Neuroinflammation In Alzheimer's Disease Pathway 3/24/2025

    Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

  2. Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights 3/5/2025

    Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

  3. Characterize Lentiviral Vector Quality Attributes Using CE Platform Technology 8/14/2023

    Review this outline of a platform-based approach using capillary electrophoresis (CE) to mitigate the technical difficulties in characterizing LVVs for the assessment of multiple quality attributes.

  4. Unravelling Immunological Depths: Exploring Oxazolone-Induced Delayed-Type Hypersensitivity Model 3/28/2025

    Validating the oxazolone-induced DTH mouse model offers a critical platform for advancing the evaluation of therapeutic candidates for chronic inflammatory diseases, including atopic dermatitis.

  5. How To Prepare Your Specimen For Immunofluorescence Microscopy 5/30/2023

    What is Immunofluorescence (IF) Microscopy, and how do you perform IF procedures to acquire the best quality data?

  6. Overcoming Challenges To High-Concentration Formulation Development 3/25/2025

    Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

  7. Identify And Mitigate Absorption Risks With PBPK Modeling 3/12/2024

    See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

  8. Industry Leading Hybridoma Technique For Accelerated Antibody Discovery 3/27/2025

    Leverage the power of hybridoma technology for efficient monoclonal antibody development, ensuring native gene pairing, class switch recombination, and seamless scalability.

  9. Accelerating Clinical Development: Modern Tools In Process Chemistry 1/23/2025

    Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

  10. Cell Line Development: Research Cell Banks In 5 Months 3/27/2025

    By leveraging cutting-edge technologies and refined methodologies, see how researchers can streamline cell line development, enhancing both productivity and scalability.